semaglutide month 3 dose Wegovy (Semaglutide) Dosing Schedule – Apothera Semaglutide Before and After 1

A new study published in the journal JCO Oncology Practice found that women categorized as overweight who use GLP-1s had a reduced chance of developing breast cancer

Future research should focus on elucidating the detailed molecular mechanisms underlying the actions of GLP-1R in both diseases and exploring the development of GLP-1R agonists with dual therapeutic benefits for AD and DM

At follow-up, unadjusted analyses showed lower HbA1c in the GLP-1RA group (36 vs 44 mmol/mol, p = 0.03), but adjusted models revealed no statistically significant monthly HbA1c change ( 1.1, p = 0.308)

But thats where their similarities stop

doi: 10.1016/bs.afnr.2017.11.003 170